Correlation Between Arrowhead Pharmaceuticals and BioNTech

Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arrowhead Pharmaceuticals and BioNTech SE, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and BioNTech.

Diversification Opportunities for Arrowhead Pharmaceuticals and BioNTech

0.92

Correlation Coefficient

Arrowhead Pharmaceuticals  BioNTech

Almost no diversification

The 3 months correlation between Arrowhead and BioNTech is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and BioNTech go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and BioNTech

Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to under-perform the BioNTech. In addition to that, Arrowhead Pharmaceuticals is 1.1 times more volatile than BioNTech SE. It trades about -0.12 of its total potential returns per unit of risk. BioNTech SE is currently generating about -0.07 per unit of volatility. If you would invest  11,258  in BioNTech SE on December 30, 2024 and sell it today you would lose (1,763) from holding BioNTech SE or give up 15.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Arrowhead Pharmaceuticals  vs.  BioNTech SE

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Arrowhead Pharmaceuticals and BioNTech

The main advantage of trading using opposite Arrowhead Pharmaceuticals and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Arrowhead Pharmaceuticals and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.